Phospha 250 Neutral Interactions
There are 71 drugs known to interact with Phospha 250 Neutral (potassium phosphate/sodium phosphate), along with 9 disease interactions. Of the total drug interactions, 28 are major, 28 are moderate, and 15 are minor.
- View all 71 medications that may interact with Phospha 250 Neutral
- View Phospha 250 Neutral disease interactions (9)
Most frequently checked interactions
View interaction reports for Phospha 250 Neutral (potassium phosphate / sodium phosphate) and the medicines listed below.
- albuterol
- amlodipine
- aspirin
- atorvastatin
- Bactrim (sulfamethoxazole / trimethoprim)
- calcitriol
- CellCept (mycophenolate mofetil)
- folic acid
- furosemide
- gabapentin
- levothyroxine
- lisinopril
- lorazepam
- losartan
- magnesium oxide
- metformin
- metoprolol
- mycophenolate mofetil
- omeprazole
- ondansetron
- pantoprazole
- potassium chloride
- prednisone
- Prograf (tacrolimus)
- sertraline
- tacrolimus
- trazodone
- Valcyte (valganciclovir)
- Vitamin D3 (cholecalciferol)
- Zyrtec (cetirizine)
Phospha 250 Neutral disease interactions
There are 9 disease interactions with Phospha 250 Neutral (potassium phosphate / sodium phosphate) which include:
- sodium/water balance
- inflammatory bowel disease
- intestinal obstruction disorders
- hypocalcemia
- phosphate imbalance
- electrolyte imbalance
- aluminum toxicity/renal impairment
- cardiac disease
- hypomagnesemia
Report options
QR code containing a link to this page
More about Phospha 250 Neutral (potassium phosphate / sodium phosphate)
- Phospha 250 Neutral consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: minerals and electrolytes
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
